Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Biosocieties|January 30, 2023
Challenges facing the clinical adoption of a new prognostic biomarker: a case studyTrine Schifter Larsen, Jesper Eugen-Olsen, Ove Andersen, et al.
Journal of Clinical Medicine|January 8, 2023
Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-AnalysisMaria Rasmussen, Jon Ambæk Durhuus, Mef Nilbert, et al.
European Journal of Ageing|September 23, 2017
Prevalence and overlap of Disease Management Program diseases in older hospitalized patientsHelle Gybel Juul-Larsen, Janne Petersen, Ditte Maria Sivertsen, et al.
Health & Social Care in the Community|March 1, 2018
Homeless people's experiences of medical respite care following acute hospitalisation in DenmarkMaja Pedersen, Camilla Bring, Nina Brünés, et al.
Journal of Medical Virology|December 22, 2007
Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapyOve Andersen, Jesper Eugen-Olsen, Kristian Kofoed, et al.
The Journal of Infection|March 11, 2008
suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAARTOve Andersen, Jesper Eugen-Olsen, Kristian Kofoed, et al.
Clinical Chemistry|May 13, 2006
Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technologyKristian Kofoed, Uffe Vest Schneider, Troels Scheel, et al.
Plos One|August 30, 2019
Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosisEmilie Garnæs, Christian Mortensen, Lise Hobolth, et al.
Pageof 21